Market revenue in 2023 | USD 16.7 million |
Market revenue in 2030 | USD 33.7 million |
Growth rate | 10.6% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 58.08% in 2023. Horizon Databook has segmented the Switzerland deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
The deep brain stimulation devices market in Switzerland is estimated to exhibit constant growth rate over the forecast period. This can be attributed to increasing geriatric population and growing prevalence of neurological diseases.
Companies are continuously trying to develop new devices and focusing on research activities. Moreover, favorable insurance policies contribute to the market growth.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account